CVS Health Corporation
CVS
$65.19
-$0.13-0.20%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 370.66B | 367.25B | 361.86B | 359.66B | 356.62B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 370.66B | 367.25B | 361.86B | 359.66B | 356.62B |
| Cost of Revenue | 321.41B | 316.53B | 309.85B | 307.32B | 303.35B |
| Gross Profit | 49.25B | 50.71B | 52.00B | 52.34B | 53.28B |
| SG&A Expenses | 41.23B | 41.15B | 40.42B | 39.89B | 39.19B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 362.64B | 357.69B | 350.27B | 347.21B | 342.54B |
| Operating Income | 8.02B | 9.56B | 11.59B | 12.46B | 14.08B |
| Income Before Tax | 6.15B | 6.73B | 9.64B | 9.87B | 11.17B |
| Income Tax Expenses | 1.56B | 1.72B | 2.44B | 2.52B | 2.81B |
| Earnings from Continuing Operations | 4.59K | 5.01K | 7.20K | 7.35K | 8.37K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 28.00M | 6.00M | -14.00M | -29.00M | -24.00M |
| Net Income | 4.61B | 5.02B | 7.19B | 7.32B | 8.34B |
| EBIT | 8.02B | 9.56B | 11.59B | 12.46B | 14.08B |
| EBITDA | 12.62B | 14.14B | 16.14B | 16.96B | 18.45B |
| EPS Basic | 3.67 | 3.95 | 5.64 | 5.71 | 6.49 |
| Normalized Basic EPS | 3.60 | 4.11 | 4.96 | 5.31 | 6.10 |
| EPS Diluted | 3.66 | 3.95 | 5.63 | 5.70 | 6.47 |
| Normalized Diluted EPS | 3.59 | 4.10 | 4.95 | 5.29 | 6.07 |
| Average Basic Shares Outstanding | 5.03B | 5.06B | 5.09B | 5.12B | 5.14B |
| Average Diluted Shares Outstanding | 5.05B | 5.08B | 5.11B | 5.14B | 5.16B |
| Dividend Per Share | 2.66 | 2.60 | 2.54 | 2.48 | 2.42 |
| Payout Ratio | 73.10% | 66.07% | 45.29% | 43.61% | 37.54% |